Journal of Medical Molecular Biology ›› 2026, Vol. 23 ›› Issue (4): 452-457.doi: 10.3870/j.issn.1672-8009.2026.04.012

• Original Articles • Previous Articles     Next Articles

Therapeutic Effect and Mechanism of Ropivacaine in Mice Model of Allergic Rhinitis

WANG Huan1, ZHANG He2, YIN Meng3, ZHANG Huinan1, LIU Guang1, GUO Jifeng1   

  1. 1Department of Anesthesiology and Surgical Anesthesiology,2Department of Respiratory Medicine,Baoding Hospital,Beijing Children’s Hospital,Capital Medical University,Baoding,Hebei,071000,China
    3Department of Anesthesiology,Guang’anmen Hospital Baoding Hospital,Chinese Academy of Traditional Chinese Medicine,Baoding,Hebei,071000,China
  • Received:2025-12-09 Published:2026-09-28
  • Contact: WANG Huan(E-mail:smkwh666@163.com)

Abstract: Objective To explore the effect of ropivacaine on alleviating ovalbumin(OVA)-induced allergic rhinitis(AR)in mice. Methods Mice were randomly divided into 5 groups:control group,AR group,low-dose Ropivacaine group(1 mg/kg),high-dose Ropivacaine group(5 mg/kg)and Dexamethasone(Dex)positive group(2 mg/kg),with 5 mice in each group.Indicator evaluations were conducted after the last drug administration. Results The body weight of mice in the high-dose Ropivacaine group and Dex group was greater than that in the AR group(P<0.05),and the relative spleen weight,the times of nose rubbing,sneezing and runny nose,levels of serum histamine,OVA-specific immunoglobulin E(IgE),total IgE,total IgG1 and β-hexosaminidase,levels of iIL-1β,IL-6,TNF-α,IL-4 and IL-5 in nasal lavage fluid and the protein expression levels of p65 and p-IkBα in the nasal mucosa were lower than those in the AR group(P<0.05).Eosinophil infiltration was reduced. Conclusion High-dose ropivacaine can relieve OVA-induced rhinitis symptoms and inflammatory infiltration of nasal mucosa of mice with AR.The mechanism may be related to the inhibition of NF-κB signaling pathway.

Key words: ropivacaine, ovalbumin, allergic rhinitis, cytokines, NF-κB signaling pathway

CLC Number: